OrganOx Metra

Asset

Normothermic machine perfusion device maintaining donor liver viability ex situ

Stage: Approved
Modality: Device
Target: Not known; 2
Indications: 0
Trials: 1
Developer

Indications

2

Liver preservation
Approved, doi.org, 1 Oct 2026
Donor liver preservation
Preclinical, doi.org, 1 Oct 2026

In the full profile

Owner and partners1
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.